Klotho Neurosciences, Inc.
KLTO
$0.48
$0.049.78%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -44.89% | 318.15% | 136.16% | 1,572.72% | 2,220.86% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -35.45% | 378.49% | 136.16% | 1,572.72% | 2,220.86% |
| Operating Income | 35.45% | -378.49% | -136.16% | -1,572.72% | -2,220.86% |
| Income Before Tax | 2.16% | -806.38% | -232.44% | -1,534.23% | -1,953.71% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 2.16% | -806.38% | -232.44% | -1,534.23% | -1,953.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.16% | -806.38% | -232.44% | -1,534.23% | -1,953.71% |
| EBIT | 35.45% | -378.49% | -136.16% | -1,572.72% | -2,220.86% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 72.53% | -318.75% | -82.88% | -803.57% | -1,766.32% |
| Normalized Basic EPS | 71.68% | -284.44% | -82.37% | -813.46% | -1,695.00% |
| EPS Diluted | 72.22% | -318.75% | -82.88% | -659.00% | -1,700.00% |
| Normalized Diluted EPS | 71.68% | -284.44% | -82.37% | -813.46% | -1,695.00% |
| Average Basic Shares Outstanding | 256.02% | 116.55% | 81.91% | 79.92% | 10.30% |
| Average Diluted Shares Outstanding | 256.02% | 116.55% | 81.91% | 79.92% | 10.30% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |